Related Experiment Video
Updated: Jul 14, 2026
10:32
Athymic Rat Model for Evaluation of Engineered Anterior Cruciate Ligament Grafts
Published on: March 26, 2015
Reoperation for bioprosthetic mitral structural failure: risk assessment.
W R E Jamieson1, L H Burr, R T Miyagishima
1University of British Columbia, Vancouver, BC, Canada. wrej@interchange.ubc.ca
Circulation
|September 13, 2003
Summary
Mitral bioprosthetic failure reoperation mortality risk is reduced with elective procedures in lower New York Heart Association (NYHA) classes. Early patient evaluation enables timely, lower-risk interventions for bioprosthetic valve deterioration.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Clinical Outcomes Research
Background:
- Structural valve deterioration is a primary complication of bioprosthetic valves, often necessitating reoperation.
- Reoperation for bioprosthetic mitral valve failure carries significant mortality risks.
- Assessing and mitigating these risks is crucial for patient management.
Purpose of the Study:
- To determine the mortality rates associated with mitral bioprosthetic failure.
- To identify and evaluate risk factors influencing mortality after reoperation for bioprosthetic mitral valve failure.
Main Methods:
- Retrospective analysis of 2,152 mitral bioprosthetic operations performed between 1975 and 1999.
- Inclusion of 481 reoperations for structural valve deterioration.
- Multivariate regression analysis to identify predictive factors for mortality.
Main Results:
- Overall reoperation mortality was 7.1% (34 fatalities).
- Mortality was significantly lower for elective/urgent reoperations (6.0%) compared to emergent (17.8%).
- Mortality decreased over time, with the lowest rates observed from 1993-2000 (3.4%).
- Predictive factors included age at implant/explant, urgency, and NYHA class; however, for 1993-2000, only age remained significant.
Conclusions:
- Mitral bioprosthetic reoperation mortality can be reduced through elective procedures in patients with low to medium NYHA functional class.
- Routine patient evaluation facilitates earlier interventions, leading to lower reoperative risk.
- Optimizing surgical timing and patient selection are key to improving outcomes.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...